User profiles for S. Alnasser

Sulaiman Mohammed Alnasser

- Verified email at qu.edu.sa - Cited by 459

Sara Alnasser

- Verified email at berkeley.edu - Cited by 5

Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry

…, D Ciaburri, R Shemin, S Alnasser… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives : This study sought to evaluate the outcomes of the early experience of transcatheter
mitral valve replacement (TMVR) with balloon-expandable valves in patients with severe …

Review on mechanistic strategy of gene therapy in the treatment of disease

SM Alnasser - Gene, 2021 - Elsevier
… Further, the modified virus is allowed to infect the affected patients and then the virus inserts
the missing human gene into the patient’s cells. Thus the infected cell now contains the copy …

Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry

…, J Mewa, P Jiménez-Quevedo, S Alnasser… - Journal of the American …, 2016 - jacc.org
… The final statistical model was built using a forward approach and Akaike’s and Schwarz’s
bayesian criteria. For the Cox models, Martingale residuals were used to examine the …

A cardiac computed tomography–based score to categorize mitral annular calcification severity and predict valve embolization

…, D Holzhey, A Pershad, C Witzke, S Alnasser… - Cardiovascular …, 2020 - jacc.org
Objectives This study aims to establish a computed tomography (CT)–based scoring system
for grading mitral annular calcification (MAC) severity and potentially aid in predicting valve …

Late consequences of acute coronary syndromes: global registry of acute coronary events (GRACE) follow-up

SMA Alnasser, W Huang, JM Gore, PG Steg… - The American journal of …, 2015 - Elsevier
… Follow-up at 6 months was prospective and based primarily on individual patient contact;
reliance on information from the patient's family, physician(s), and on hospital or central …

Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement

…, V Serra, H Eltchaninoff, SM Alnasser… - JACC: Cardiovascular …, 2016 - jacc.org
… The indication for TAVR and approach were assessed by each center’s heart team, and
TAVR … for APT; in all the others centers the strategy was at the treating physician’s discretion. …

Enhanced heavy metals removal by a novel carbon nanotubes buckypaper membrane containing a mixture of two biopolymers: Chitosan and i-carrageenan

A Alshahrani, A Alharbi, S Alnasser, M Almihdar… - Separation and …, 2021 - Elsevier
… The MWCNTs/chitosan-carrageenan membrane was also found to be mechanically
robust, with a tensile strength and Young’s modulus of 30.69 ± 2.6 MPa and 3.78 ± 0.03 GPa, …

Long term outcomes among adults post transcatheter atrial septal defect closure: systematic review and meta-analysis

S Alnasser, D Lee, PC Austin, C Labos, M Osten… - International Journal of …, 2018 - Elsevier
… Statistical heterogeneity was assessed using the I 2 statistic(s) with p value of <0.05 defining
the statistical significance. Sensitivity analysis was carried out re calculating the weighted …

Amniotic fluid disorders and the effects on prenatal outcome: a retrospective cohort study

H Bakhsh, H Alenizy, S Alenazi, S Alnasser… - BMC pregnancy and …, 2021 - Springer
Background The amniotic fluid is a protective liquid present in the amniotic sac. Two types
of amniotic fluid disorders have been identified. First refers to polyhydramnios, which is an …

Incidence, predictors and clinical outcomes of residual stenosis after aortic valve-in-valve

…, MJ Reardon, A Chhatriwalla, VG Ribeiro, S Alnasser… - Heart, 2018 - heart.bmj.com
Objective We aimed to analyse the incidence of prosthesis–patient mismatch (PPM) and
elevated gradients after aortic valve in valve (ViV), and to evaluate predictors and associations …